I take moonshot ideas from 0-to-1, translating ambiguous opportunities into structured plans and orchestrating cross-functional teams.

Currently lead Special Projects at , where we're building an AI-first commercial health plan focused on accessibility and simplicity. We recently raised our Series B at a $1.3B valuation.

I work with the founders to innovate new products, validate hypothesis, and drive impact in a fast-moving, regulated environment.



Recent Projects

Baseline Visit

A virtual or in-person onboarding experience that pairs every Curative member with a Care Navigator and clinician to understand their benefits and leave with a personalized care plan.

Cash Card

A payment card for Curative members to swipe at the front desk and get their care covered at $0. Built to widen access and take the friction out of paying for it.

COVID-19 Testing & Vaccines

Helped build Curative's COVID-19 testing lab, which scaled to conduct 10% of the nation's COVID tests. Then built its vaccine program from scratch, delivering 2M+ doses nationally through mobile units and at mass sites like Dodgers Stadium.

Education

B.S. in Biochemistry — UCLA 2015 – 2019

Departmental Honors

Publications

Kojima, N., Mores, C., Farsai, N., Klausner, J. Duration of SARS-CoV-2 Viral Culture Positivity. Clinical Microbiology and Infection Journal. (2021).

Research

  • Bio-Rad Laboratories Hematology diagnostics product development
  • UCLA Lusis Lab Cardiovascular genomics research on the transcriptional network regulating atherosclerosis resistance
  • UCLA Yeates Lab Structural biology research focused on bacterial microcompartment proteins (MCPs)

© 2026 Noreen Farsai